Ingredient: KL sublimation medicinal preparation 80%, dextrorotary alkyne fifth heavenly stem chrysanthemum ester 2-3%, function medicinal preparation 1- 3%.
KL升华剂80%,右旋炔戊菊酯2-3%,功能剂1- 3%。
Ingredient: KL sublimation medicinal preparation 80%, dextrorotary alkyne fifth heavenly stem chrysanthemum ester 2-3%, function medicinal preparation 1- 3%.
KL升华剂80%,右旋炔戊菊酯2-3%,功能剂1- 3%。
Conclusion: The early use of salivia miltiorrhia, low molecular dextrar and dipyridamole can effectively prevent and treat the portal thrombosis after portal-azygous disconnection.
早期使用丹参、低分子右旋糖酐、潘生丁能更有效防治门奇断门静脉
血栓形
度变化。
声明:以上例句、词性分类均由互联网资源自动生,部分未经过人工审核,其表达内容亦不代表本软件
观点;若发现问题,欢迎向我们指正。
Ingredient: KL sublimation medicinal preparation 80%, dextrorotary alkyne fifth heavenly stem chrysanthemum ester 2-3%, function medicinal preparation 1- 3%.
KL升华剂80%,右旋炔戊菊酯2-3%,功能剂1- 3%。
Conclusion: The early use of salivia miltiorrhia, low molecular dextrar and dipyridamole can effectively prevent and treat the portal thrombosis after portal-azygous disconnection.
早期使用丹参、低子右旋
、
生丁能更有效防治门奇断流术后门静脉
血栓形成的长度变化。
声明:以上例句、词性由互联网资源自动生成,部
未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Ingredient: KL sublimation medicinal preparation 80%, dextrorotary alkyne fifth heavenly stem chrysanthemum ester 2-3%, function medicinal preparation 1- 3%.
KL升华剂80%,右旋炔戊菊酯2-3%,功能剂1- 3%。
Conclusion: The early use of salivia miltiorrhia, low molecular dextrar and dipyridamole can effectively prevent and treat the portal thrombosis after portal-azygous disconnection.
早期使用丹参、低分子右旋糖酐、潘生丁能更有效防治门奇断流术后门静脉血栓形成的长度变化。
声明:以上、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内
代表本软件的观点;若发现问题,欢迎向我们指正。
Ingredient: KL sublimation medicinal preparation 80%, dextrorotary alkyne fifth heavenly stem chrysanthemum ester 2-3%, function medicinal preparation 1- 3%.
KL升华剂80%,右旋炔戊菊酯2-3%,功能剂1- 3%。
Conclusion: The early use of salivia miltiorrhia, low molecular dextrar and dipyridamole can effectively prevent and treat the portal thrombosis after portal-azygous disconnection.
早期使用丹参、低子右旋糖
、
丁能更有效防治门奇断流术后门静脉
血栓形成的长度变化。
声明:以上例句、词均由互联网资源自动
成,部
未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Ingredient: KL sublimation medicinal preparation 80%, dextrorotary alkyne fifth heavenly stem chrysanthemum ester 2-3%, function medicinal preparation 1- 3%.
KL升华剂80%,右旋炔戊菊酯2-3%,功能剂1- 3%。
Conclusion: The early use of salivia miltiorrhia, low molecular dextrar and dipyridamole can effectively prevent and treat the portal thrombosis after portal-azygous disconnection.
早期使用丹参、低分子右旋糖酐、潘生丁能更有效防治门奇后门静脉
血栓形成
变化。
声明:以上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件观点;若发现问题,欢迎向我们指正。
Ingredient: KL sublimation medicinal preparation 80%, dextrorotary alkyne fifth heavenly stem chrysanthemum ester 2-3%, function medicinal preparation 1- 3%.
KL升华剂80%,右旋炔戊菊酯2-3%,功能剂1- 3%。
Conclusion: The early use of salivia miltiorrhia, low molecular dextrar and dipyridamole can effectively prevent and treat the portal thrombosis after portal-azygous disconnection.
早期使用丹参、低分子右旋糖酐、潘生丁能更有门奇断流术后门静脉
血栓形成的长度变化。
:
上例句、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Ingredient: KL sublimation medicinal preparation 80%, dextrorotary alkyne fifth heavenly stem chrysanthemum ester 2-3%, function medicinal preparation 1- 3%.
KL升华剂80%,右旋炔戊菊酯2-3%,功能剂1- 3%。
Conclusion: The early use of salivia miltiorrhia, low molecular dextrar and dipyridamole can effectively prevent and treat the portal thrombosis after portal-azygous disconnection.
早期使用丹参、低分子右旋糖酐、潘生丁能更有效防治门奇断流术后门静脉血栓形成的长度变化。
声明:以上、词性分类均由互联网资源自动生成,部分未经过人工审核,其表达内容
表本软件的观点;若发现问题,欢迎向我们指正。
Ingredient: KL sublimation medicinal preparation 80%, dextrorotary alkyne fifth heavenly stem chrysanthemum ester 2-3%, function medicinal preparation 1- 3%.
KL升华剂80%,右旋炔戊菊酯2-3%,功能剂1- 3%。
Conclusion: The early use of salivia miltiorrhia, low molecular dextrar and dipyridamole can effectively prevent and treat the portal thrombosis after portal-azygous disconnection.
早期参、低分子右旋糖酐、潘
丁能更有效防治门奇断流术后门静脉
血栓形成的长度变化。
声明:以上例句、词性分类均由互联网资源成,部分未经过人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。
Ingredient: KL sublimation medicinal preparation 80%, dextrorotary alkyne fifth heavenly stem chrysanthemum ester 2-3%, function medicinal preparation 1- 3%.
KL升华剂80%,右旋炔戊菊2-3%,
剂1- 3%。
Conclusion: The early use of salivia miltiorrhia, low molecular dextrar and dipyridamole can effectively prevent and treat the portal thrombosis after portal-azygous disconnection.
早期使用丹参、低分子右旋糖酐、潘生丁更有效防治门奇断流术后门静脉
血栓形成的长度变化。
声明:以上例句、词性分类均由互联网资源自动生成,部分人工审核,其表达内容亦不代表本软件的观点;若发现问题,欢迎向我们指正。